In conclusion, in our study, we have demonstrated a significant association between immunohistochemical expression of STING and high-grade (G3–G4) metastatic clear cell renal cell carcinomas, in contrast to organ-confined low-grade (G1–G2) lesions which have less frequently expressed this marker. Here, STING1 is linked to clear cell renal carcinoma.